We have identified and characterized a new molecular defect of SCN9A in a young patient with CIP, hyposmia and hypogeusia that widens the spectrum of Nav1.7 impairments underlying this phenotype, and have demonstrated the effect of the mutation on whole blood transcript assay. Here, SCN9A is linked to hereditary sensory and autonomic neuropathy.